Cgpc, officially known as Chang Gung Pharmaceutical Corporation, is a prominent player in the pharmaceutical industry, headquartered in Taiwan (TW). Established in 1964, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, including prescription medications and over-the-counter solutions. With a strong operational presence across Asia, Cgpc is renowned for its commitment to innovation and quality, particularly in the fields of biotechnology and generic pharmaceuticals. The company’s core offerings are distinguished by their rigorous adherence to international standards and a focus on patient safety. Cgpc has achieved notable recognition in the market, positioning itself as a trusted name in healthcare. Its dedication to research and development has led to several key milestones, solidifying its reputation as a leader in the pharmaceutical sector.
How does Cgpc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Plastic production industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cgpc's score of 36 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Cgpc reported total carbon emissions of approximately 15,130,000 kg CO2e for Scope 1, 16,830,000 kg CO2e for Scope 2, and 139,490,000 kg CO2e for Scope 3, totalling about 171,450,000 kg CO2e. This reflects a significant increase in emissions compared to previous years, particularly in Scope 3 emissions. In 2022, the company recorded total emissions of approximately 385,620,000 kg CO2e, with Scope 1 emissions at about 151,239,000 kg CO2e, Scope 2 at approximately 168,141,000 kg CO2e, and Scope 3 emissions reaching around 1,394,848,000 kg CO2e. Over the years, Cgpc's emissions have fluctuated, with Scope 1 emissions increasing from about 4,959,000 kg CO2e in 2017 to 15,130,000 kg CO2e in 2023. Scope 2 emissions also rose from approximately 10,098,000 kg CO2e in 2017 to 16,830,000 kg CO2e in 2023. Notably, Scope 3 emissions were not reported until 2021, when they reached approximately 1,421,469,000 kg CO2e. Despite these figures, Cgpc has not established specific reduction targets or climate pledges, indicating a potential area for improvement in their climate commitments. The absence of documented reduction initiatives suggests that the company may need to enhance its strategies to address its carbon footprint effectively.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2017 | 2018 | 2019 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|
Scope 1 | 4,959,000 | 0,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 2 | 10,098,000 | 00,000,000 | 0,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | - | - | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cgpc is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.